Fremanezumab in Children and Adolescents with Episodic Migraine - Part 2
In part two of this series, Dr. Tesha Monteith and Dr. Andrew Hershey discuss appropriate treatment strategies to prevent migraines in children and adolescents. Show citation: Hershey AD, Szperka CL…
Read the full articleYou might also wanna read
CGRP monoclonal antibody fremanezumab may reduce weather-triggered migraine attacks, study finds
Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention
mdsc.pe·21d ago
CME | This Is Giving Me a Headache: Managing the Headache Patient Without Losing Your Mind
In this re-released episode of CME on the Go, originally published on 12/1/2025, our hosts discuss the complexities of diagnosing and treati
CME | Stimulants & Strategy: Integrating ADHD Treatments Into Daily Practice
In this episode of CME on the go, recorded live at FMX in Anaheim, our hosts discuss the complexities of ADHD treatment. They cover initial
CME | This Is Giving Me a Headache: Managing the Headache Patient Without Losing Your Mind
In this episode of CME on the Go, our hosts discuss the complexities of diagnosing and treating headaches in primary care. They cover common
Intranasal Zavegepant for the acute treatment of migraine in adults: A review of randomized clinical trials
Migraine is a highly prevalent chronic neurological disorder and one of the leading causes of disability worldwide. Among recent therapeutic
Comments
Sign in to join the conversation.
No comments yet. Be the first.